Bb Biotech | WebDisclosure

Basculer en Français

10161	Companies
208736	Keywords
138859	Articles
110648	Press releases

Home
Companies
Bb Biotech

PRESS RELEASE

published on 05/20/2024 at 12:53, 1 year 10 months ago

Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
Edison issues review on BB Biotech (BION), highlighting its performance improvement and optimistic outlook in the recovering biotech sector, offering investors an opportunity for acquisition at an attractive level

Investors Edison Biotech Sector BB Biotech Review
BRIEF

published on 04/26/2024 at 07:05, 1 year 11 months ago

BB Biotech AG Announces Strong First Quarter Results in 2024 Interim Report

Financial Performance Net Profit BB Biotech AG Interim Report 2024 Biotechnology Investments
BRIEF

published on 04/26/2024 at 07:05, 1 year 11 months ago

BB Biotech AG annonce de solides résultats du premier trimestre dans son rapport intermédiaire 2024

Performance Financière Bénéfice Net BB Biotech SA Rapport Intermédiaire 2024 Investissements En Biotechnologie
BRIEF

published on 04/26/2024 at 07:05, 1 year 11 months ago

BB Biotech Reports Strong First Quarter Amidst Biotech Market Uncertainties

Financial Results Biotechnology Healthcare Sector Investment Strategy BB Biotech
BRIEF

published on 04/26/2024 at 07:05, 1 year 11 months ago

BB Biotech annonce un premier trimestre solide dans un contexte d'incertitudes sur le marché de la biotechnologie

Résultats Financiers Biotechnologie Stratégie D'investissement Secteur De La Santé BB Biotechnologie
PRESS RELEASE

published on 04/26/2024 at 07:00, 1 year 11 months ago

EQS-Adhoc: BB Biotech AG publishes its interim report
BB Biotech AG publishes its interim report for the first quarter of 2024, revealing a net profit of CHF 260 million. The report includes details on the company's investment activities and performance

Investment Company Net Profit BB Biotech AG Interim Report Business Activities
PRESS RELEASE

published on 04/26/2024 at 07:00, 1 year 11 months ago

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
BB Biotech reports solid first-quarter results as interest rates impact biotech stock market. Net profit reaches CHF 260 mn. Key portfolio adjustments and milestones highlighted

Interest Rates First-quarter Results BB Biotech Biotech Stock Market Portfolio Adjustments
BRIEF

published on 03/21/2024 at 18:05, 2 years ago

BB Biotech AG's Shareholders Approve Dividend and Elect New Chairman

Board Of Directors Annual General Meeting Shareholders Dividend BB Biotech AG
BRIEF

published on 03/21/2024 at 18:05, 2 years ago

Les actionnaires de BB Biotech AG approuvent le dividende et élisent un nouveau président

Actionnaires Conseil D'administration Dividende Assemblée Générale Annuelle BB Biotech SA
PRESS RELEASE

published on 03/21/2024 at 18:00, 2 years ago

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
Shareholders at BB Biotech AG's AGM approved a dividend of CHF 2.00 per share along with other proposals. Dr. Thomas von Planta elected as new Chairman

Shareholders Dividend AGM BB Biotech AG Dr. Thomas Von Planta

Accesswire

Published on 04/02/2026 at 22:00, 1 day 19 hours ago

Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 1 day 22 hours ago

Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 2 days 2 hours ago

Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 days 2 hours ago

Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 days 2 hours ago

Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution

View all ACCESSWIRE

EQS Group

Published on 04/04/2026 at 10:07, 7 hours 6 minutes ago

Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 15 hours 7 minutes ago

Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 23 hours 12 minutes ago

IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 23 hours 12 minutes ago

IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 23 hours 27 minutes ago

Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems

Les Echos

Published on 04/03/2026 at 18:46, 22 hours 26 minutes ago

Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 22 hours 26 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 23 hours 11 minutes ago

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 23 hours 12 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 23 hours 13 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026

View all LES ECHOS COMFI WIRE